Literature DB >> 12202576

High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.

José E Levi1, Bernhard Kleter, Wim G V Quint, Maria C S Fink, Cynthia L M Canto, Regina Matsubara, Iara Linhares, Aluísio Segurado, Bart Vanderborght, José Eluf Neto, Leen-Jan Van Doorn.   

Abstract

A group of 208 human immunodeficiency virus (HIV)-infected women in Brazil were studied for the presence of human papillomavirus with the general SPF(10) PCR primer set. Virtually all (98%) women were found positive for human papillomavirus (HPV) DNA. Genotyping by the reverse hybridization line probe assay (HPV-LiPA) revealed a high prevalence of multiple genotypes (78.9% of the cases), with an average of 3.1 genotypes per patient (range, 1 to 10 genotypes). HPV 6 was the most prevalent genotype and was observed in 80 (39.2%) patients, followed by types 51 (31.9%), 11 (26.0%), 18 (24.0%), and 16 (22.5%). Of the genotypes detected, 40.9% were low-risk genotypes. Twenty-two (10.5%) patients showed normal (Pap I) cytology, 149 (71.6%) patients had inflammation (Pap II), and 28 patients (13.4%) had a Pap III score. The prevalence of high-risk genotypes increased with the cytological classification. There were no significant associations between the number of HPV genotypes detected and the cytological classification, HIV viral load, and CD4 count in these patients. In conclusion, the highly sensitive SPF(10) LiPA system shows that a very high proportion of HIV-infected women in Brazil are infected with HPV and often carry multiple HPV genotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202576      PMCID: PMC130803          DOI: 10.1128/JCM.40.9.3341-3345.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping.

Authors:  W G Quint; G Scholte; L J van Doorn; B Kleter; P H Smits; J Lindeman
Journal:  J Pathol       Date:  2001-05       Impact factor: 7.996

3.  Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay.

Authors:  Leen-Jan van Doorn; Wim Quint; Bernhard Kleter; Anco Molijn; Brigitte Colau; Marie-Thérèse Martin; Norah Torrez-Martinez; Cheri L Peyton; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.

Authors:  L Ahdieh; A Muñoz; D Vlahov; C L Trimble; L A Timpson; K Shah
Journal:  Am J Epidemiol       Date:  2000-06-15       Impact factor: 4.897

Review 5.  Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions.

Authors:  J S Mandelblatt; M Fahs; K Garibaldi; R T Senie; H B Peterson
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

6.  Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).

Authors:  I Heard; J M Tassie; V Schmitz; L Mandelbrot; M D Kazatchkine; G Orth
Journal:  Obstet Gynecol       Date:  2000-09       Impact factor: 7.661

7.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

8.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Human papillomavirus testing in primary cervical screening.

Authors:  J Cuzick; A Szarewski; G Terry; L Ho; A Hanby; P Maddox; M Anderson; G Kocjan; S T Steele; J Guillebaud
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

View more
  54 in total

1.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

2.  High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.

Authors:  Paul H M Smits; Remco Bakker; Eefje Jong; Jan Willem Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim G V Quint
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil.

Authors:  Mayara Costa Mansur Tavares; Jamilly Lopes de Macêdo; Sérgio Ferreira de Lima Júnior; Sandra de Andrade Heráclio; Melânia Maria Ramos Amorim; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

4.  Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Authors:  David H Adler; Lisa Kakinami; Tebogo Modisenyane; Nkeko Tshabangu; Lerato Mohapi; Guy De Bruyn; Neil A Martinson; Tanvier Omar
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

Review 5.  AIDS related malignancies in Brazil.

Authors:  Julio Sampaio; Carlos Brites; Iguaracyra Araujo; Carlos E Bacchi; Dirk P Dittmer; Paula Y Tanaka; William Harrington; Eduardo M Netto
Journal:  Curr Opin Oncol       Date:  2007-09       Impact factor: 3.645

6.  Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa.

Authors:  Andrew J Desruisseau; Delf Schmidt-Grimminger; Edith Welty
Journal:  Infect Dis Obstet Gynecol       Date:  2010-02-09

7.  Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.

Authors:  Markus Schmitt; Christophe Depuydt; Ina Benoy; Johannes Bogers; Jerome Antoine; Marc Arbyn; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

8.  Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.

Authors:  Markus Schmitt; Bolormaa Dondog; Tim Waterboer; Michael Pawlita; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.

Authors:  Angela Watt; David Garwood; Maria Jackson; Novie Younger; Camille Ragin; Monica Smikle; Horace Fletcher; Norma McFarlane-Anderson
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

10.  High Prevalence of Human Papillomavirus Infection among Brazilian Pregnant Women with and without Human Immunodeficiency Virus Type 1.

Authors:  Emilia Moreira Jalil; Geraldo Duarte; Patrícia El Beitune; Renata Toscano Simões; Patrícia Pereira Dos Santos Melli; Silvana Maria Quintana
Journal:  Obstet Gynecol Int       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.